Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Affiliated Hospital of Qingdao University

Authors not listed

The Affiliated Hospital of Qingdao University · 2021

Abstract

Sarcopenia is a common complication in liver cirrhosis patients and has been confirmed that associated with poor prognosis. China has the world's largest burden of hepatitis B virus-related liver cirrhosis (HBV-related liver cirrhosis). However, the relationship between HBV-related liver cirrhosis patients with muscle mass loss and normal muscle mass is remain largely unknown. Our study aimed to reveal the metabolic profile and identify potential biomarkers of muscle mass loss in HBV-related liver cirrhosis.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-07-02 MST

Cite this

APA
Anonymous. (2021). Affiliated Hospital of Qingdao University. <em>The Affiliated Hospital of Qingdao University</em>. https://clinicaltrials.gov/study/NCT05041348
Vancouver
Anonymous. Affiliated Hospital of Qingdao University. The Affiliated Hospital of Qingdao University. 2021.
BibTeX
@misc{anon2021Affili, title = {Affiliated Hospital of Qingdao University}, author = {Anonymous}, journal = {The Affiliated Hospital of Qingdao University}, year = {2021}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.